Companies Cryptocurrencies
Histogen Inc
Histogen Inc
Exchange: NasdaqGS
IPO Date: 25/07/2013
CEO: Mr. Richard W. Pascoe
Biotechnology Healthcare 🔗
  • HSTO
  • 0.1593
  • 7957067
    market cap
  • -0.0063
If you bought

shares of Histogen Inc (HSTO) on
You would have made
Old Price $12 Current Price $12

Histogen Inc., formerly Conatus Pharmaceuticals Inc., is a regenerative medicine company. The Company is focused on developing technologies that replace and regenerates tissues in the body. The company’s technology platform utilizes cell conditioned media and extracellular matrix materials produced by hypoxia-induced multipotent cells, developing therapeutic products that address unmet medical needs. The Company has product candidates in clinical development intended to address and offer treatment for hair loss, dermal filler and treatment for joint cartilage repair. The Company manufactures a soluble multipotent cell conditioned media (CCM), which is the starting material for products for hair growth, skin care and other applications. In addition to this, the Company also manufactures an insoluble extracellular matrix (ECM) for applications such as orthopedics, wound care and soft tissue augmentation.

Address: 16745 West Bernardo Drive Suite 250 San Diego CALIFORNIA 92121

Stay updated.